Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.608.018.728.867.21

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 8.60 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.60
Mar20248.01
Mar20238.72
Mar20228.86
Mar20217.21

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 8.6
7.37
Mar2024 8.01
-8.14
Mar2023 8.72
-1.58
Mar2022 8.86
22.88
Mar2021 7.21 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹132.2 Cr -2.8% -8% -35.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,567.0 Cr 0.5% 4.6% -18.2% Stock Analytics
DIVIS LABORATORIES ₹151,601.0 Cr -3.2% -6.7% 4.4% Stock Analytics
CIPLA ₹122,284.0 Cr 0.3% -3.5% -10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,593.0 Cr 0.9% -0.6% 3.5% Stock Analytics
DR REDDYS LABORATORIES ₹104,014.0 Cr -2.2% -0.9% -9.4% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-2.8%

-8%

-35.4%

SENSEX

-0.9%

0.8%

-5.7%


You may also like the below Video Courses